Iloprost in der Behandlung der Präeklampsie – klinische Pilotstudie engl.: oral Iloprost in pre-eclampsia treatment - a pilot study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-015828-28-AT

Enrollment

Unknown

Registered

2009-12-01

Start date

2010-01-28

Completion date

Unknown

Last updated

2016-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early- onset Pre-eclampsia MedDRA version: 12.0 Level: LLT Classification code 10036485 Term: Pre-eclampsia

Interventions

Trade Name: Ilomedin 10 microgramm / 0,5ml Infusionslösungskonzentrat Product Name: Ilomedin Infusionslösung 10 mcg/0,5ml Pharmaceutical Form: Intravenous infusion INN or Proposed INN: ILOPROST TROMET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pregnancy 24- 34+6 gestational weeks pre-eclampsia informed consent age between 18 - 39 years singular pregnancies Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: malignant diseases renal diseases liver diseases multiple gestations coronary heart disease of the mother heart valve disease of the mother congenital or obtaind heart anomalies of the mother thrombophilia hemophilia anticoagulation excluding low dose lmw heparine all circumstances that unable patients to understand the study and consequences proteinuria over 2g per day age under 18 or over 39 years

Design outcomes

Primary

Measure	Time frame
Main Objective: Effect of Iloprost oral: Decrease of proteinuria in parturients with early onset pre-eclampsia under 0.3g / day;Secondary Objective: Effect of iloprost oral on augmentation index, blood pressure and Nt-pro BNP in parturients with pre-eclampsia;Primary end point(s): decrease of proteinuria under 0.3 g / day	—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026